Ultralife Corporation (ULBI) is a publicly traded Industrials sector company. As of May 21, 2026, ULBI trades at $6.12 with a market cap of $101.61M and a P/E ratio of -0.15. ULBI moved +0.17% today. Year to date, ULBI is +0.17%; over the trailing twelve months it is +7.73%. Its 52-week range spans $4.07 to $10.09. Rallies surfaces ULBI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded ULBI stock?
Rallies tracks politician and congressional stock disclosures for ULBI, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
WHITMORE BRADFORD T bought 53.13K (~$359.11K) on Mar 16, 2026.
WHITMORE BRADFORD T bought 100.64K (~$636.49K) on Mar 13, 2026.
WHITMORE BRADFORD T bought 33.74K (~$201.31K) on Mar 12, 2026.
ULBI Analyst Consensus
ULBI analyst coverage data. Average price target: $0.00.
Common questions about ULBI
Which politicians traded ULBI stock?
Rallies tracks politician and congressional stock disclosures for ULBI, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ULBI?
Yes. Rallies tracks politician and congressional stock disclosures for ULBI, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ULBI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ULBI. It does not provide personalized investment advice.
